At NYC makeathon, students change lives with technology

At an April 21-23 makeathon in New York City, Cornell students worked to help improve the lives of 17 people with disabilities.

Study challenges diagnostic approach to urological condition

Kidney ultrasound plus a visual examination of the bladder and urethra appears to be the most cost-effective way to screen for cancers of the genitourinary tract of those with blood in their urine.

African circumcision rates rise when clergy endorse procedure

Educating religious leaders in sub-Saharan Africa about male circumcision increases the likelihood that men will undergo the procedure, Weill Cornell Medicine investigators found in a new trial.

Entrepreneurship: A developing ecosystem of, through and beyond Cornell

Through research, coursework, fellowships, leadership initiatives, business incubators, community outreach, business plan competitions and more, an evolving entrepreneurial ecosystem has emerged at Cornell.

Ezra

Takao Hensch wins Mortimer D. Sackler, MD Prize

Takao Hensch, professor of neurology at Harvard Medical School's Boston Children's Hospital, has won the Mortimer D. Sackler, MD Prize for Distinguished Achievement in Developmental Psychobiology.

Women with healthy BMI may have higher risk of breast cancer

Women with a healthy body mass index may be at risk of breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process, Weill Cornell Medicine research finds.

NIH allergist awarded Drukier Prize by Weill Cornell Medicine

Dr. Joshua Milner, an allergist and immunologist who has made key discoveries into the origin of previously unidentified disorders that affect children, has been awarded the Drukier Prize.

Brain stents improve head pressure and vision loss

Weill Cornell Medicine researchers find that brain stents successfully treat symptoms of Idiopathic intracranial hypertension such as head pressure and vision loss.

Three-pronged approach is key to precision medicine

Combining genetic information from tumor cells with 3-D cell cultures grown from these tumors, and rapidly screening approved drugs, can identify the best treatment approaches in patients.